Allison R Jarstad, DO
Ophthalmology · Medford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · Cataract and Laser Institute of Southern Oregon PC · 5 clinicians in this group
Looking this up.
Hospitals listed: Asante Rogue Regional Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Jarstad’s office at (541) 779-2020 to ask if they take your plan before you enroll.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Asante Rogue Regional Medical CenterMedford, ORAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Asante Health System, which runs 3 hospitalsPatients rate it 3 of 5 · 75% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.221, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.252, Oct 2024 – Sep 2025
See every measure and the patient survey for Asante Rogue Regional Medical Center
Behind the star rating — Deaths: 1 better, 7 the same, 0 worse of 8 measures. Safety: 2 better, 4 the same, 0 worse of 6 measures. Readmissions: 4 better, 6 the same, 0 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.221 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.252 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.69 (0 to 1.57) · 1,701 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.06 (0.82 to 1.31) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 180.29 (142.35 to 218.23) · 179 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.2 · 238 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 9.3 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.3 · 317 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.5 · 410 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.5 · 278 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.7 · 390 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.7 · 4,099 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.31) · 7,066 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.05 to 0.42) · 7,782 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.47 (0.71 to 4.23) · 2,618 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.34 (1.1 to 3.59) · 1,195 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.27 (1.02 to 3.53) · 2,377 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 12 (7.91 to 16.09) · 1,111 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.39 (4.43 to 10.36) · 1,142 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.33 (0.94 to 3.73) · 510 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.5 (0 to 1.06) · 6,730 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.587 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.444 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.6 · 492 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 17.4 · 555 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 5.8 · 370 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -26.8 · 435 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 14 · 292 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 422 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.3 (4.9 to 8.1) · 573 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.4 (7.6 to 11.7) · 573 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for CABGUnplanned return visits | 7.8 · 222 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 135 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (9.9 to 16.3) · 1,200 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.9 to 1.4) · 762 cases | No different | Jan 2024 – Dec 2024 |
What patients said (2,449 patients answered, 42% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 73% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 84% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 75% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 69% |
| Nurses "always" explained things so they could understand | 74% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 51% |
| "YES", patients would definitely recommend the hospital | 75% |
| Staff "always" explained possible side effects | 45% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
Original Medicare doctor bills
$217,617
Medicare paid this office $217,617 for 622 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Removal of cataract with insertion of prosthetic lens | 103 | $53,950 | $360 |
| Established patient complete exam of visual system | 322 | $25,906 | $76 |
| Removal of recurring cataract in lens capsule using a laser | 56 | $16,194 | $213 |
| Return visit (30+ min) | 141 | $13,817 | $81 |
| Complex removal of cataract with insertion of prosthetic lens | 20 | $12,025 | $501 |
See all 19 services
| Removal of cataract with insertion of prosthetic lens | 103 | $53,950 | $360 |
| Established patient complete exam of visual system | 322 | $25,906 | $76 |
| Removal of recurring cataract in lens capsule using a laser | 56 | $16,194 | $213 |
| Return visit (30+ min) | 141 | $13,817 | $81 |
| Complex removal of cataract with insertion of prosthetic lens | 20 | $12,025 | $501 |
| Established patient problem focused exam of visual system | 117 | $8,862 | $61 |
| Closure of tear duct opening using plug | 35 | $6,163 | $99 |
| New patient visit (45+ min) | 66 | $6,046 | $92 |
| Imaging of retina | 188 | $5,458 | $26 |
| Measurement of corneal curvature and depth of eye | 138 | $5,282 | $29 |
| Ct scan of cornea | 147 | $4,071 | $24 |
| Microfluid analysis of tears | 67 | $3,679 | $22 |
| Short return visit (20+ min) | 45 | $3,053 | $59 |
| Exam of visual field with extended testing | 57 | $2,979 | $44 |
| Laser repair to improve eye fluid flow | 11 | $2,510 | $148 |
| New patient complete exam of visual system | 27 | $2,502 | $93 |
| Imaging of optic nerve | 73 | $1,994 | $23 |
| Imaging of front third of eye | 60 | $1,271 | $19 |
| Exam of the internal drainage system of eye | 21 | $466 | $19 |
Procedures Medicare counted
| Cataract surgery | 251 | More than 87% of doctors who do this |
Who their Medicare patients are
622 Original Medicare patients in 2024. Average age 76 · Under 65 4% · 85 and older 12% · Women 63% · Also on Medicaid 10% · Health risk score 1.07. At or below the middle of the specialty; the typical ophthalmology clinician is at 1.16.
Conditions among them: High blood pressure 66% · Diabetes 26% · Chronic kidney disease 18% · Depression 18% · Coronary heart disease 17% · Atrial fibrillation 17% · Cancer 16% · COPD 14% · Heart failure 11% · Stroke 8% · Dementia 5%.
The office billed $621,920, Medicare allowed $303,019 and paid $217,617; for 3,905 services of 65 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 622 | 3,905 | 76 | 1.07 | $621,920 | $217,617 |
| 2023 | 765 | 3,174 | 75 | 0.99 | $939,703 | $284,609 |
| 2022 | 527 | 1,822 | 75 | 1.05 | $548,822 | $172,812 |
| 2021 | 416 | 1,441 | 75 | 1.38 | $529,450 | $135,757 |
| 2020 | 314 | 1,003 | 74 | 1.42 | $362,385 | $98,584 |
| 2019 | 23 | 25 | 75 | 1.64 | $14,414 | $2,291 |
| 2018 | 49 | 62 | 75 | 1.82 | $159,437 | $5,640 |
| 2017 | 47 | 62 | 74 | 1.84 | $81,452 | $5,287 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 23 services
| Removal of cataract with insertion of prosthetic lens | 128 | $82,408 | $389 |
| Established patient complete exam of visual system | 296 | $26,661 | $85 |
| Return visit (30+ min) | 222 | $26,192 | $87 |
| New patient visit (45+ min) | 184 | $18,880 | $103 |
| Established patient problem focused exam of visual system | 165 | $16,355 | $63 |
| Complex removal of cataract with insertion of prosthetic lens | 18 | $10,888 | $518 |
| Measurement of corneal curvature and depth of eye | 217 | $9,357 | $29 |
| Imaging of retina | 243 | $8,469 | $29 |
| Removal of recurring cataract in lens capsule using a laser | 24 | $7,912 | $233 |
| Closure of tear duct opening using plug | 38 | $7,425 | $106 |
| Microfluid analysis of tears | 105 | $6,939 | $22 |
| New patient complete exam of visual system | 73 | $6,736 | $92 |
| Ct scan of cornea | 241 | $6,664 | $24 |
| Creation of eye fluid drainage tracts in iris using a laser, per session | 13 | $3,984 | $181 |
| Exam of visual field with extended testing | 68 | $3,268 | $45 |
| Short return visit (20+ min) | 41 | $2,859 | $68 |
| Imaging of optic nerve | 64 | $1,669 | $25 |
| Imaging of front third of eye | 36 | $814 | $22 |
| Exam of the internal drainage system of eye | 28 | $675 | $22 |
| Photography of content of eyes | 13 | $323 | $18 |
| Other service or procedure on eye | 16 | $178 | $10 |
| Extended exam of the back part of the eye with optic nerve drawing | 15 | $166 | $10 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 11 | $10 | None |
2022: 19 services
| Removal of cataract with insertion of prosthetic lens | 59 | $35,638 | $392 |
| Return visit (30+ min) | 133 | $15,922 | $93 |
| Established patient complete exam of visual system | 177 | $15,284 | $80 |
| New patient visit (45+ min) | 135 | $14,811 | $110 |
| Established patient problem focused exam of visual system | 141 | $12,519 | $62 |
| Removal of recurring cataract in lens capsule using a laser | 31 | $9,014 | $225 |
| New patient complete exam of visual system | 89 | $8,665 | $97 |
| Closure of tear duct opening using plug | 25 | $5,125 | $102 |
| Measurement of corneal curvature and depth of eye | 100 | $4,961 | $31 |
| Ct scan of cornea | 131 | $4,518 | $25 |
| Imaging of retina | 122 | $4,431 | $29 |
| Exam of visual field with extended testing | 38 | $1,913 | $47 |
| Imaging of optic nerve | 36 | $1,100 | $26 |
| Short return visit (20+ min) | 14 | $989 | $71 |
| Photography of the retina | 41 | $842 | $21 |
| Microfluid analysis of tears | 16 | $707 | $22 |
| Insertion of drug delivery implant into tear duct of eye | 17 | $325 | $12 |
| Exam of the internal drainage system of eye | 12 | $309 | $22 |
| Photography of content of eyes | 12 | $184 | $15 |
2021: 14 services
| Established patient problem focused exam of visual system | 215 | $29,175 | $74 |
| Removal of cataract with insertion of prosthetic lens | 29 | $21,073 | $458 |
| Established patient complete exam of visual system | 163 | $15,314 | $92 |
| New patient complete exam of visual system | 84 | $9,762 | $116 |
| Photography of the retina | 235 | $7,432 | $31 |
| Removal of recurring cataract in lens capsule using a laser | 19 | $6,262 | $272 |
| Exam of visual field with extended testing | 71 | $4,625 | $56 |
| Measurement of corneal curvature and depth of eye | 43 | $2,075 | $25 |
| Imaging of optic nerve | 55 | $1,792 | $29 |
| Imaging of retina | 47 | $1,732 | $35 |
| Short return visit (20+ min) | 13 | $1,146 | $76 |
| Ct scan of cornea | 20 | $693 | $32 |
| Ultrasound scan of cornea to determine thickness | 35 | $400 | $10 |
| Exam of the internal drainage system of eye | 11 | $229 | $21 |
2020: 13 services
| Established patient problem focused exam of visual system | 186 | $25,880 | $78 |
| Removal of cataract with insertion of prosthetic lens | 20 | $12,670 | $453 |
| Established patient complete exam of visual system | 101 | $11,104 | $108 |
| New patient complete exam of visual system | 53 | $6,408 | $121 |
| Photography of the retina | 129 | $5,285 | $39 |
| Removal of recurring cataract in lens capsule using a laser | 14 | $4,162 | $277 |
| Exam of visual field with extended testing | 42 | $2,856 | $58 |
| Measurement of corneal curvature and depth of eye | 33 | $1,997 | $29 |
| Imaging of optic nerve | 39 | $1,376 | $31 |
| Imaging of retina | 25 | $850 | $34 |
| New patient problem focused exam of visual system | 12 | $846 | $71 |
| Ct scan of cornea | 12 | $379 | $29 |
| Ultrasound scan of cornea to determine thickness | 22 | $226 | $10 |
2019: 1 service
| Short return visit (20+ min) | 16 | $641 | $40 |
2018: 2 services
| Transplantation of outer layer of corneal tissue | 14 | $2,835 | $167 |
| Short return visit (20+ min) | 13 | $349 | $25 |
2017: 1 service
| Short return visit (20+ min) | 19 | $1,043 | $43 |
Medicaid work
$20,069 in 2024
Medicaid paid $20,069 for 354 billed services this clinician did in 2024, up to 31 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 81 | $5,985 |
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 81 | $5,142 |
| Return visit (30+ min) | 34 | $2,425 |
| OPH SVCS MEDICAL XM&EVAL COMPRE NEW PT 1/> VST | 14 | $1,798 |
| New patient visit (45+ min) | 16 | $1,758 |
| DETERMINATION REFRACTIVE STATE | 70 | $1,066 |
| Short return visit (20+ min) | 13 | $789 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina | 18 | $562 |
| COMPUTERIZED CORNEAL TOPOGRAPHY UNI/BI W/I&R | 27 | $542 |
| 2024 | 354 | 9 | 31 | $20,069 |
| 2023 | 1,829 | 12 | 44 | $105,744 |
| 2022 | 1,144 | 10 | 41 | $72,467 |
See the largest Medicaid services in earlier years
2023
| New patient visit (45+ min) | 173 | $20,788 |
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 318 | $20,226 |
| OPH SVCS MEDICAL XM&EVAL COMPRE NEW PT 1/> VST | 162 | $19,206 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 201 | $16,797 |
| Return visit (30+ min) | 203 | $15,418 |
| DETERMINATION REFRACTIVE STATE | 341 | $4,930 |
| COMPUTERIZED CORNEAL TOPOGRAPHY UNI/BI W/I&R | 129 | $3,030 |
| Ophthalmic biometry by partial coherence interferometry with intraocular lens power calculation | 89 | $2,016 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina | 84 | $1,997 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; optic nerve | 24 | $719 |
| Visual field examination, unilateral or bilateral, with interpretation and report; extended examination (eg, Goldmann visual fields with at least 3 isopters plotted and static determination within the central 30°, or quantitative, automated threshold perimetry, Octopus program G-1, 32 or 42, Humphrey visual field analyzer full threshold programs 30-2, 24-2, or 30/60-2) | 15 | $612 |
| Microfluidic analysis utilizing an integrated collection and analysis device, tear osmolarity | 90 | $7 |
2022
| OPH SVCS MEDICAL XM&EVAL COMPRE NEW PT 1/> VST | 195 | $21,286 |
| New patient visit (45+ min) | 152 | $16,218 |
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 227 | $14,797 |
| XCAPSL CTRC RMVL INSJ IO LENS PROSTH W/O ECP | 15 | $5,634 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 72 | $5,231 |
| DETERMINATION REFRACTIVE STATE | 301 | $4,009 |
| Return visit (30+ min) | 70 | $3,119 |
| COMPUTERIZED CORNEAL TOPOGRAPHY UNI/BI W/I&R | 56 | $882 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina | 37 | $767 |
| Ophthalmic biometry by partial coherence interferometry with intraocular lens power calculation | 19 | $525 |
Drugs they prescribed that Part D paid
$235,123
Pharmacies billed $235,123 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
1,075 generic and 486 brand-name prescriptions · $235,123 in drug cost · 29 antibiotic prescriptions to 16 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Prednisolone Acetate | 407 | $19,131 | $47 |
| Restasis | 11 | $6,971 | $634 |
| Ketorolac Tromethamine | 335 | $4,678 | $14 |
| Ofloxacin | 360 | $3,983 | $11 |
| Latanoprost | 94 | $1,859 | $20 |
See all 13 drugs
| Prednisolone Acetate | 407 | $19,131 | $47 |
| Restasis | 11 | $6,971 | $634 |
| Ketorolac Tromethamine | 335 | $4,678 | $14 |
| Ofloxacin | 360 | $3,983 | $11 |
| Latanoprost | 94 | $1,859 | $20 |
| Valacyclovir | 26 | $915 | $35 |
| Timolol Maleate | 55 | $797 | $14 |
| Brimonidine | 27 | $734 | $27 |
| Neomycin-Polymyxin-Dexameth | 56 | $615 | $11 |
| Doxycycline Hyclate | 17 | $577 | $34 |
| Atropine Sulfate | 11 | $570 | $52 |
| Erythromycin | 47 | $507 | $11 |
| Dorzolamide-Timolol | 12 | $62 | $5 |
Year by year
| 2024 | 1,561 | 438 | None | 31% | $235,123 |
| 2023 | 2,067 | 571 | None | 32% | $261,494 |
| 2022 | 1,638 | 537 | None | 35% | $876,467 |
| 2021 | 2,876 | 766 | None | 38% | $612,413 |
| 2020 | 1,607 | 551 | 0% (0) | 39% | $456,380 |
| 2019 | 99 | 54 | 0% (0) | 65% | $31,368 |
| 2018 | 1,165 | 365 | None | 60% | $286,561 |
| 2017 | 724 | 302 | None | 46% | $105,084 |
| 2016 | 153 | 42 | 0% (0) | 29% | $8,142 |
| 2015 | 97 | 35 | None | 34% | $4,567 |
| 2014 | 66 | 30 | None | None | $1,170 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 14 drugs
| Prednisolone Acetate | 549 | $31,146 | $57 |
| Restasis | 11 | $9,661 | $878 |
| Xiidra | 14 | $9,624 | $687 |
| Ketorolac Tromethamine | 480 | $8,460 | $18 |
| Ofloxacin | 509 | $7,467 | $15 |
| Doxycycline Hyclate | 11 | $2,505 | $228 |
| Neomycin-Polymyxin-Dexameth | 100 | $1,510 | $15 |
| Erythromycin | 105 | $1,131 | $11 |
| Latanoprost | 58 | $1,113 | $19 |
| Doxycycline Monohydrate | 40 | $1,080 | $27 |
| Valacyclovir | 26 | $717 | $28 |
| Timolol Maleate | 35 | $466 | $13 |
| Brimonidine | 16 | $320 | $20 |
| Polymyxin B Sul-Trimethoprim | 15 | $191 | $13 |
2022: 22 drugs
| Oxervate | 23 | $724,469 | $31,499 |
| Restasis | 34 | $42,050 | $1,237 |
| Xiidra | 35 | $24,151 | $690 |
| Prednisolone Acetate | 263 | $14,763 | $56 |
| Combigan | 14 | $6,635 | $474 |
| Latanoprost | 210 | $5,987 | $29 |
| Valacyclovir | 45 | $4,659 | $104 |
| Ketorolac Tromethamine | 222 | $3,686 | $17 |
| Loteprednol Etabonate | 12 | $3,537 | $295 |
| Ofloxacin | 259 | $3,454 | $13 |
| Travoprost | 12 | $3,141 | $262 |
| Simbrinza | 13 | $2,885 | $222 |
| Doxycycline Hyclate | 29 | $2,127 | $73 |
| Brimonidine | 32 | $1,954 | $61 |
| Timolol Maleate | 51 | $1,782 | $35 |
| Dorzolamide-Timolol | 54 | $1,332 | $25 |
| Neomycin-Polymyxin-Dexameth | 88 | $1,255 | $14 |
| Fluorometholone | 15 | $1,244 | $83 |
| Erythromycin | 97 | $1,078 | $11 |
| Dorzolamide | 18 | $955 | $53 |
| Moxifloxacin | 12 | $487 | $41 |
| Doxycycline Monohydrate | 12 | $296 | $25 |
2021: 22 drugs
| Oxervate | 12 | $362,200 | $30,183 |
| Restasis | 55 | $50,017 | $909 |
| Xiidra | 45 | $43,013 | $956 |
| Prednisolone Acetate | 533 | $21,303 | $40 |
| Combigan | 42 | $19,979 | $476 |
| Latanoprost | 429 | $11,132 | $26 |
| Rhopressa | 23 | $10,204 | $444 |
| Travoprost | 26 | $7,800 | $300 |
| Alphagan P | 12 | $7,628 | $636 |
| Valacyclovir | 79 | $7,011 | $89 |
| Rocklatan | 13 | $6,444 | $496 |
| Simbrinza | 19 | $6,202 | $326 |
| Ketorolac Tromethamine | 274 | $6,069 | $22 |
| Dorzolamide-Timolol | 147 | $5,562 | $38 |
| Ofloxacin | 338 | $5,032 | $15 |
| Brimonidine | 118 | $4,378 | $37 |
| Doxycycline Hyclate | 90 | $3,519 | $39 |
| Timolol Maleate | 123 | $3,320 | $27 |
| Erythromycin | 183 | $2,587 | $14 |
| Dorzolamide | 44 | $2,508 | $57 |
| Neomycin-Polymyxin-Dexameth | 114 | $1,863 | $16 |
| Fluorometholone | 14 | $1,050 | $75 |
2020: 19 drugs
| Oxervate | 13 | $316,751 | $24,365 |
| Restasis | 32 | $44,153 | $1,380 |
| Prednisolone Acetate | 313 | $12,890 | $41 |
| Xiidra | 18 | $12,485 | $694 |
| Combigan | 23 | $9,460 | $411 |
| Travoprost | 18 | $6,228 | $346 |
| Latanoprost | 214 | $4,568 | $21 |
| Valacyclovir | 57 | $4,149 | $73 |
| Brimonidine | 39 | $2,911 | $75 |
| Ofloxacin | 208 | $2,729 | $13 |
| Doxycycline Hyclate | 55 | $2,602 | $47 |
| Dorzolamide-Timolol | 61 | $2,292 | $38 |
| Neomycin-Polymyxin-Dexameth | 117 | $2,087 | $18 |
| Ketorolac Tromethamine | 70 | $1,759 | $25 |
| Erythromycin | 109 | $1,368 | $13 |
| Fluorometholone | 13 | $1,344 | $103 |
| Timolol Maleate | 55 | $873 | $16 |
| Dorzolamide | 20 | $844 | $42 |
| Polymyxin B Sul-Trimethoprim | 11 | $94 | $9 |
2019: 3 drugs
| Restasis | 24 | $23,040 | $960 |
| Prednisolone Acetate | 18 | $1,059 | $59 |
| Latanoprost | 12 | $55 | $5 |
2018: 22 drugs
| Restasis | 229 | $165,214 | $721 |
| Xiidra | 76 | $58,020 | $763 |
| Prednisolone Acetate | 196 | $9,745 | $50 |
| Lotemax | 39 | $9,013 | $231 |
| Moxifloxacin | 66 | $3,698 | $56 |
| Durezol | 18 | $3,102 | $172 |
| Alphagan P | 13 | $2,711 | $209 |
| Combigan | 11 | $1,797 | $163 |
| Valacyclovir | 27 | $1,653 | $61 |
| Latanoprost | 60 | $1,007 | $17 |
| Ketorolac Tromethamine | 47 | $947 | $20 |
| Doxycycline Hyclate | 20 | $872 | $44 |
| Fluorometholone | 12 | $827 | $69 |
| Timolol Maleate | 31 | $709 | $23 |
| Acyclovir | 40 | $652 | $16 |
| Dorzolamide-Timolol | 33 | $650 | $20 |
| Brimonidine | 29 | $504 | $17 |
| Ofloxacin | 32 | $499 | $16 |
| Doxycycline Monohydrate | 11 | $279 | $25 |
| Polymyxin B Sul-Trimethoprim | 25 | $213 | $9 |
| Erythromycin | 22 | $209 | $9 |
| Minocycline | 11 | $35 | $3 |
2017: 18 drugs
| Restasis | 71 | $43,537 | $613 |
| Xiidra | 23 | $13,283 | $578 |
| Prednisolone Acetate | 112 | $6,610 | $59 |
| Lotemax | 18 | $4,682 | $260 |
| Combigan | 16 | $3,373 | $211 |
| Vigamox | 19 | $2,742 | $144 |
| Moxifloxacin | 32 | $2,728 | $85 |
| Brimonidine | 33 | $1,777 | $54 |
| Valacyclovir | 19 | $1,318 | $69 |
| Doxycycline Hyclate | 20 | $1,077 | $54 |
| Ketorolac Tromethamine | 34 | $884 | $26 |
| Ofloxacin | 44 | $881 | $20 |
| Latanoprost | 44 | $764 | $17 |
| Dorzolamide-Timolol | 32 | $731 | $23 |
| Bimatoprost | 11 | $691 | $63 |
| Timolol Maleate | 19 | $566 | $30 |
| Erythromycin | 34 | $416 | $12 |
| Acyclovir | 22 | $239 | $11 |
2016: 4 drugs
| Brimonidine | 21 | $670 | $32 |
| Latanoprost | 33 | $390 | $12 |
| Timolol Maleate | 13 | $388 | $30 |
| Dorzolamide-Timolol | 22 | $374 | $17 |
2015: 3 drugs
| Prednisolone Acetate | 16 | $656 | $41 |
| Erythromycin | 16 | $229 | $14 |
| Latanoprost | 13 | $192 | $15 |
Money from drug and device companies
$592 in 2025
| 2025 | 10 | 16 | None | $592 |
| 2024 | 9 | 13 | None | $380 |
| 2023 | 9 | 23 | None | $1,037 |
| 2022 | 11 | 30 | None | $1,187 |
| 2021 | 11 | 36 | None | $1,670 |
| 2020 | 6 | 11 | $3,000 | $3,263 |
| 2019 | 6 | 15 | None | $606 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Biotissue Holdings | None | $163 | 4 payments
|
| Johnson & Johnson Surgical Vision | Tecnis Iol | $127 | 2 payments
|
| RxSight | Rxsight Contact Lens | $110 | 2 payments
|
| Glaukos | Photrexa Viscous and Photrexa | $58 | 2 payments
|
| Abbvie | Lumigan | $32 | 1 payment
|
| Amgen | Tepezza | $25 | 1 payment
|
See all 16 published payments
| Bausch & Lomb Americas | Meals · 2025-11-20 | Vyzulta | $22 |
| Biotissue Holdings | Meals · 2025-11-18 | None | $8 |
| Johnson & Johnson Surgical Vision | Meals · 2025-10-29 | Tecnis Iol | $85 |
| Dompe US | Meals · 2025-08-28 | Oxervate | $18 |
| Amgen | Meals · 2025-05-15 | Tepezza | $25 |
| Sun Pharmaceutical Industries | Meals · 2025-05-15 | Cequa | $16 |
| Glaukos | Meals · 2025-05-08 | Kxl System (Not Refurbished) | $17 |
| Johnson & Johnson Surgical Vision | Meals · 2025-04-09 | Tecnis Iol | $42 |
| Tarsus Pharmaceuticals | Meals · 2025-04-01 | Xdemvy | $21 |
| Abbvie | Meals · 2025-03-26 | Lumigan | $32 |
| Glaukos | Meals · 2025-03-04 | Photrexa Viscous and Photrexa | $41 |
| Biotissue Holdings | Meals · 2025-02-26 | None | $7 |
| RxSight | Meals · 2025-02-11 | Rxsight Contact Lens | $22 |
| Biotissue Holdings | Meals · 2025-01-29 | None | $81 |
| RxSight | Meals · 2025-01-19 | Rxsight Contact Lens | $88 |
| Biotissue Holdings | Meals · 2025-01-03 | None | $67 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $380
| Alcon Vision | Hydrus Microstent | $154 | 2 payments
|
| Johnson & Johnson Surgical Vision | Tecnis Iol | $64 | 2 payments
|
| Bausch & Lomb Americas | Xiidra | $34 | 2 payments
|
| Biotissue Holdings | None | $31 | 2 payments
|
| Abbvie | Qulipta | $26 | 1 payment
|
| RxSight | Rxsight Contact Lens | $23 | 1 payment
|
| Alimera Sciences | Yutiq | $18 | 1 payment
|
| Tarsus Pharmaceuticals | Xdemvy | $17 | 1 payment
|
| New World Medical | Kahook Dual Blade | $14 | 1 payment
|
2023: $1,037
| Sight Sciences | Tearcare System | $297 | 3 payments
|
| RxSight | Rxsight Contact Lens | $228 | 5 payments
|
| Nova Eye | None | $172 | 2 payments
|
| Johnson & Johnson Surgical Vision | Tecnis Simplicity | $152 | 2 payments
|
| Sun Pharmaceutical Industries | Cequa | $45 | 3 payments
|
| Bausch & Lomb Americas | Miebo | $43 | 2 payments
|
| New World Medical | None | $40 | 3 payments
|
| Novartis Pharmaceuticals | Xiidra | $40 | 2 payments
|
| Alcon Vision | Rocklatan | $19 | 1 payment
|
2022: $1,187
| Alcon Vision | Acrysof Iq Panoptix Uv Iol | $294 | 4 payments
|
| Novartis Pharmaceuticals | Xiidra | $217 | 10 payments
|
| BioTissue Holdings | Prokera | $136 | 2 payments
|
| Johnson & Johnson Surgical Vision | Tecnis Iol | $117 | 2 payments
|
| Kala Pharmaceuticals | Inveltys | $112 | 1 payment
|
| Alexion Pharmaceuticals | Ultomiris | $98 | 1 payment
|
| Bausch & Lomb Americas | Vyzulta | $62 | 4 payments
|
| Glaukos | Istent Inject W | $57 | 1 payment
|
| Sun Pharmaceutical Industries | Cequa | $50 | 2 payments
|
| New World Medical | Kahook Dual Blade | $25 | 2 payments
|
| Oyster Point Pharma | Tyrvaya | $20 | 1 payment
|
2021: $1,670
| Alcon Vision | Acrysof Iq Panoptix | $580 | 8 payments
|
| Glaukos | Istent Inject W | $413 | 5 payments
|
| Aerie Pharmaceuticals | Rhopressa | $273 | 10 payments
|
| Ivantis | Hydrus Microstent | $149 | 1 payment
|
| RxSight | Light Adjustable Lens (Lal) and Light Delivery Device (Ldd) | $90 | 3 payments
|
| Bausch & Lomb a division of Bausch Health US | Prolensa | $39 | 2 payments
|
| Sight Sciences | Tearcare Smartlid | $34 | 2 payments
|
| New World Medical | Ahmed Glaucoma Valve | $33 | 2 payments
|
| Allergan | Lumigan | $23 | 1 payment
|
| Dompe US | Oxervate | $22 | 1 payment
|
| Novartis Pharmaceuticals | Xiidra | $14 | 1 payment
|
2020: $3,263
| Glaukos | Istent Trabecular Micro-Bypass Stent System | $3,048 | 4 payments
|
| Bioventus | Exogen | $115 | 1 payment
|
| Allergan | Restasis | $47 | 3 payments
|
| Dompe US | Oxervate | $21 | 1 payment
|
| New World Medical | Ahmed Glaucoma Valve | $19 | 1 payment
|
| TissueTech | Prokera | $13 | 1 payment
|
2019: $606
| Allergan | Restasis | $163 | 3 payments
|
| Bausch & Lomb a division of Bausch Health US | Envista Toric | $148 | 2 payments
|
| Aerie Pharmaceuticals | Rhopressa | $137 | 7 payments
|
| Alcon Vision | Acrysof | $89 | 1 payment
|
| Johnson & Johnson Surgical Vision | Tecnis 1-Piece Iol | $48 | 1 payment
|
| Omeros | Omidria | $20 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 91.8 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1265729081
- Licence
- CA 20A15543, OR DO208852
- Trained
- Pacific Nw Un of Hs, Col of Osteopathic Medicine, 2013
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 207W00000X (207W00000X)
- Mailing address
- 1408 E Barnett Rd, Medford, OR, 97504
- NPI first listed
- 2011-06-30
- NPI last updated
- 2022-02-23
- NPI record certified
- 2022-02-23
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 850 Health Sciences Road, Irvine, CA, 92697 · 3300 E South St, Lakewood, CA, 90805 · 3801 Katella Ave Ste 130, Los Alamitos, CA, 90720 · 300 Pasteur Dr, Stanford, CA, 94305 · 111 University Pkwy, Yakima, WA, 98901
This office lists an electronic records connection.